Sustainability in the pharmaceutical sector: trends, challenges and opportunities for companies

How is the pharmaceutical industry evolving?

The pharmaceutical sector Is she going through a phase of complex transformation and not linear. Today, the primary mission of ensuring access to safe, effective and timely treatment is accompanied by the urgency of rethinking production models in the light of environmental and social challenges.

With an estimated impact equal to 4.4% of global greenhouse gas emissions, higher, in proportion, than that of the automotive industry, the sector is called to drastically reduce your ecological footprint, intervening on production processes, supply chains and waste management.

However, the transition to a sustainable model meets numerous obstacles. In addition to growing European regulatory pressure and stakeholder expectations, the sector is faced with structural issues: from speculative pricing and patent protection logic, to ethical disputes related to drug testing and the use of marketing.

These elements make transparency Ed ethics two crucial priorities, but at the same time difficult to manage.

Among the main challenges What the sector is facing emerge:
‍

• Scope 3 emissions management;
• tension between sustainability and regulatory requirements;
• management of pharmaceutical waste and wastewater;
• sustainable packaging;
• digitization of processes and availability of ESG data.
  ‍

To deal with this transition effectively, a integrated approach that combines technological innovation, measurement skills, training and collaboration between all the players in the supply chain.

‍

What you'll find in this focus on the pharmaceutical sector

This study provides companies with the essential tools to understand changes in the pharmaceutical sector and define effective strategies to seize opportunities related to ESG issues.

By filling out the form you can access for free PDFS containing an analysis that explains:
‍

• challenges and opportunities within the pharmaceutical sector;
• the ways in which ESG issues are implemented;
• an in-depth analysis of what are the tools and levers of action for an effective ESG strategy.

In addition, you can access the webinars in which we will talk about:

• trends, challenges and opportunities for companies in promoting an ESG transition;
• how Enthera Pharmaceuticals and Giuliani have implemented their sustainability path with Up2You;
• ideas and useful tips for your company's sustainability strategy.